BioSpace News Archive

The Sabin Vaccine Institute (Sabin) today announced that Professor David Salisbury and Jeffrey P. Libson have been named to the Board of Trustees and Retired Major General Philip K. Russell will transition from Trustee to Special Advisor after more than 25 years of service to the organization.

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced preliminary unaudited fiscal 2020 third quarter revenue for the three months ended March 31, 2020 and withdrew its previously issued financial guidance for the Company’s fiscal 2020 performance.

RemeGen recently announced the closing of approximately USD $100 million in a private financing co-led by Lilly Asia Ventures and Lake Bleu Capital

The Alliance for Regenerative Medicine (ARM) today announced it will host a webinar on clinical trial guidance during the ongoing COVID-19 pandemic, with speakers from the U.S. Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT).

Celularity Inc. (“Celularity” or the “Company”), a clinical-stage company developing allogeneic cellular therapies from human placentas, today announced the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for the use of its proprietary CYNK-001 in adults with COVID-19.

EyeTech Digital Systems, a leader in eyetracking for health, launches FDA-registered EyeOn LifeLine, a potentially life-saving eye tracking communication tablet for hospital ERs and ICUs, so doctors, nurses and caregivers can easily and quickly communicate with their critical COVID-19 patients, who are unable to speak while confined to their hospital beds.

An international collaboration of virologists at the University of Wisconsin–Madison and the vaccine companies FluGen and Bharat Biotech has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu.

EastWest Bioscience Inc. has released its second quarter results for the three months ending January 31, 2020..

Premier Inc., a leading healthcare improvement company, is coordinating across the industry to help solve the supply chain challenges presented by COVID-19.

Calviri, Inc., a biotech startup spun out of Arizona State University Biodesign Institute, focused on ending deaths from cancer, announced the closing of $2.25 million in seed round funding.